<DOC>
	<DOCNO>NCT00466440</DOCNO>
	<brief_summary>The purpose study compare response rate prostate cancer patient take chemotherapy plus enzastaurin versus chemotherapy plus placebo .</brief_summary>
	<brief_title>A Phase 2 Study With Enzastaurin Plus Chemotherapy Placebo Plus Chemotherapy Prostate Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>You least 18 year old . You live close enough doctor 's office attend require visit . You treat chemotherapy prostate cancer . Your organ must function properly . You unable swallow pill . You another serious illness besides prostate cancer . You take another experimental drug within last 30 day . You serious heart condition . You receive another anticancer therapy .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>